相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL
Francesco Forconi et al.
BLOOD (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior
Francesco Forconi et al.
BLOOD (2009)
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy
Evgeny Arons et al.
BLOOD (2009)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Robert J. Kreitman
CURRENT PHARMACEUTICAL DESIGN (2009)
Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
Robert J. Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Defining origins of malignant B cells: a new circulating normal human IgM+D+ B-cell subset lacking CD27 expression and displaying somatically mutated IGHV genes as a relevant memory population
N. Weston-Bell et al.
LEUKEMIA (2009)
Combination therapies to improve the long-term outcome in hairy cell leukemia
Francesco Lauria et al.
LEUKEMIA & LYMPHOMA (2009)
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3
George F. Widhopf et al.
BLOOD (2008)
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia:: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz et al.
BLOOD (2008)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
Francesco Forconi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Editorial overview: Lymphocyte development
Klaus Rajewsky et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia
Francesco Forconi et al.
HAEMATOLOGICA (2008)
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
Fiona Murray et al.
BLOOD (2008)
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
Monica Else et al.
CANCER (2007)
Complete molecular remission induced by concomitant Cladribine - Rituximab treatment in a case of multi-resistant Hairy Cell Leukemia
Francesco Forconi et al.
LEUKEMIA & LYMPHOMA (2007)
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
Kostas Stamatopoulos et al.
BLOOD (2007)
B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities
Jun Li et al.
NATURE IMMUNOLOGY (2006)
Immunotoxins in the treatment of refractory hairy cell leukemia
Robert J. Kreitman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Eradication of minimal residual disease in hairy cell leukemia
F Ravandi et al.
BLOOD (2006)
Somatic hypermutation and VH gene usage in hairy cell leukaemia
E Arons et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
BL22 and lymphoid malignancies
Robert J. Kreitman et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2006)
Evolving concepts in the pathogenesis of hairy-cell leukaemia
Enrico Tiacci et al.
NATURE REVIEWS CANCER (2006)
Long remissions in hairy cell leukemia with purine analogs - A report of 219 patients with a median follow-up of 12.5 years
M Else et al.
CANCER (2005)
Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia
M Thorsélius et al.
LEUKEMIA RESEARCH (2005)
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors
K Basso et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia
BT Messmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Towards the pharmacotherapy of hairy cell leukaemia
F Lauria et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
hairy cell leukemia: at the crossroad of somatic mutation and isotype switch
F Forconi et al.
BLOOD (2004)
Chronic lymphocytic leukemia: revelations from the B-cell receptor
FK Stevenson et al.
BLOOD (2004)
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)
B Falini et al.
LANCET (2004)
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins
GF Widhopf et al.
BLOOD (2004)
VH gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin
V Vanhentenrijk et al.
LEUKEMIA (2004)
Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology
T Marafioti et al.
BLOOD (2003)
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma:: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle et al.
BLOOD (2003)
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia
J Nieva et al.
BLOOD (2003)
Extrafollicular antibody responses
ICM MacLennan et al.
IMMUNOLOGICAL REVIEWS (2003)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand
AR Ramiro et al.
NATURE IMMUNOLOGY (2003)
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
J Greeve et al.
BLOOD (2003)
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine
GR Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia
Y Vasconcelos et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Rituximab in relapsed or refractory hairy cell leukemia
DA Thomas et al.
BLOOD (2003)
Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells
P Oppezzo et al.
LEUKEMIA (2002)
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
U Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing
F Forconi et al.
BLOOD (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene
T Muto et al.
GENOMICS (2000)
分享论文
